A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

1. About lecanemab (generic name, brand name: Leqembi®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal ...

The health, physical activity and eating habits of 1,516 participants over-65s were monitored by a team of scientists in ...

The good news is research has shown that people can make changes throughout adulthood that can help prevent or delay cognitive decline and even reduce their risk of dementia. These include quitting ...

Significant year-to-year fluctuations in cholesterol levels without changes in medication may indicate that older adults have a higher risk for cognitive decline or dementia, according to preliminary ...

Exercise has been shown to improve brain health and reduce the risk of cognitive decline and dementia over the long-term. But ...

Discover how traditional Chinese medicine is unlocking potential breakthroughs to dementia prevention and cognitive health.

Components of metabolic syndrome were associated with increased risks for all-cause and vascular dementia in a linear manner.

and frontotemporal dementia. Each type has distinct characteristics and may require different approaches to management and care. The Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) ...

Caring for a loved one with Alzheimer's or another form of dementia can be a heart-wrenching journey. It's a path filled with ...

Exercise has been shown to improve brain health and reduce the risk of cognitive decline and dementia over the long-term ... daily lives using a protocol called ecological momentary assessment. Over ...